Portugal, South Korea and Spain respectively ranked numbers 2, 3 and 4 in this ranking.
How does Luxembourg perform in Cardiovascular Drug?
Forecast: Cardiac Glycosides Sales in Luxembourg
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Luxembourg
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Luxembourg
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Luxembourg
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antiarrhythmic Medicine Sales in Luxembourg
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Luxembourg
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Diuretic Medicine Sales in Luxembourg
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Cardiovascular System Medicine Sales in Luxembourg
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antiarrhythmic Medicine Sales in Luxembourg
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Antiarrhythmic Medicine Sales in Luxembourg
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research